公开(公告)号：US11903988B2

公开(公告)日：2024-02-20

申请号：US17650806

申请日：2022-02-11

Applicant: KARALLIEF INC

Inventor： Krishna Rajendran

IPC: A61K36/328 ,  A61K36/82 ,  A61P3/06 ,  A61K36/9068 ,  A61K36/8962 ,  A61K36/9066 ,  A61K36/00

CPC classification number: A61K36/328 ,  A61K36/82 ,  A61K36/8962 ,  A61K36/9066 ,  A61K36/9068 ,  A61P3/06

Abstract: A composition includes Commiphora mukul extract, Camellia sinensis extract, and Trigonella foenum-graecum extract. The composition may further include Allium sativum extract, Zingiber officinale extract, and Cinnamomum verum extract. The composition may include Commiphora mukul extract at about 24%-36% by weight of the total composition, the Allium sativum extract at about 20%-30% by weight of the total composition, the Camellia sinensis extract at about 12%-18% by weight of the total composition, the Trigonella foenum-graecum extract at about 12%-18% by weight of the total composition, the Zingiber officinale extract at about 8%-12% by weight of the total composition, and the Cinnamomum verum extract at about 4%-6% by weight of the total composition. The disclosure further provides methods of treating hyperlipidemia using the disclosed compositions.

公开(公告)号：US20230302074A1

公开(公告)日：2023-09-28

申请号：US18204044

申请日：2023-05-31

Applicant: LISA GENG

Inventor： LISA GENG

IPC: A61K36/185 ,  A61K36/27 ,  A61K36/328 ,  A61K36/9066 ,  A61K36/82 ,  A61K36/54 ,  A61K36/81 ,  A23L33/105 ,  A23L33/12 ,  A61P25/28 ,  A61K31/07 ,  A61K31/197 ,  A61K31/198 ,  A61K31/202 ,  A61K31/205 ,  A61K31/355 ,  A61K31/375 ,  A61K31/4188 ,  A61K31/4415 ,  A61K31/455 ,  A61K31/51 ,  A61K31/519 ,  A61K31/525 ,  A61K31/593 ,  A61K31/714 ,  A61K33/04 ,  A61K33/06 ,  A61K33/24 ,  A61K33/30 ,  A61K33/32 ,  A61K33/34 ,  A61K35/20 ,  A61K36/24 ,  A23L33/00 ,  A23L27/10 ,  A23L27/12

CPC classification number: A61K36/185 ,  A61K36/27 ,  A61K36/328 ,  A61K36/9066 ,  A61K36/82 ,  A61K36/54 ,  A61K36/81 ,  A23L33/105 ,  A23L33/12 ,  A61P25/28 ,  A61K31/07 ,  A61K31/197 ,  A61K31/198 ,  A61K31/202 ,  A61K31/205 ,  A61K31/355 ,  A61K31/375 ,  A61K31/4188 ,  A61K31/4415 ,  A61K31/455 ,  A61K31/51 ,  A61K31/519 ,  A61K31/525 ,  A61K31/593 ,  A61K31/714 ,  A61K33/04 ,  A61K33/06 ,  A61K33/24 ,  A61K33/30 ,  A61K33/32 ,  A61K33/34 ,  A61K35/20 ,  A61K36/24 ,  A23L33/30 ,  A23L27/10 ,  A23L27/12 ,  A23V2002/00

Abstract: Nutrient compositions comprising botanical extracts and methods of their use for treating, inter alia, autism or apraxia and/or ameliorating one or more symptoms thereof are disclosed. The use of such compositions for enhancing cognitive function and/or one or more aspects thereof, or for treating stroke or seizures and/or ameliorating one or more symptoms thereof are also disclosed.

公开(公告)号：US20230256044A1

公开(公告)日：2023-08-17

申请号：US17650806

申请日：2022-02-11

Applicant: KARALLIEF INC

Inventor： Krishna Rajendran

IPC: A61K36/328 ,  A61K36/82 ,  A61K36/9066 ,  A61K36/9068 ,  A61K36/8962 ,  A61P3/06

CPC classification number: A61K36/328 ,  A61K36/82 ,  A61K36/9066 ,  A61K36/9068 ,  A61K36/8962 ,  A61P3/06

Abstract: A composition includes Commiphora mukul extract, Camellia sinensis extract, and Trigonella foenum-graecum extract. The composition may further include Allium sativum extract, Zingiber officinale extract, and Cinnamomum verum extract. The composition may include Commiphora mukul extract at about 24%-36% by weight of the total composition, the Allium sativum extract at about 20%-30% by weight of the total composition, the Camellia sinensis extract at about 12%-18% by weight of the total composition, the Trigonella foenum-graecum extract at about 12%-18% by weight of the total composition, the Zingiber officinale extract at about 8%-12% by weight of the total composition, and the Cinnamomum verum extract at about 4%-6% by weight of the total composition. The disclosure further provides methods of treating hyperlipidemia using the disclosed compositions.

公开(公告)号：US20190125816A1

公开(公告)日：2019-05-02

申请号：US16232573

申请日：2018-12-26

Applicant: Muniyal Ayurvedic Research Centre

Inventor： M Vijayabhanu Shetty

IPC: A61K36/37 ,  A61K36/328 ,  A61P3/10 ,  A61K36/59 ,  A61K36/9066 ,  A61K36/61 ,  A61K36/9068 ,  A61K36/24 ,  A61K45/06 ,  A61K36/67 ,  A61K36/185

CPC classification number: A61K36/37 ,  A61K33/30 ,  A61K35/614 ,  A61K36/185 ,  A61K36/24 ,  A61K36/328 ,  A61K36/59 ,  A61K36/61 ,  A61K36/67 ,  A61K36/9066 ,  A61K36/9068 ,  A61K45/06 ,  A61K2300/00 ,  A61P3/10

Abstract: Herbo-mineral formulation for prevention, treatment and management of Diabetes and method of preparing the same are disclosed herein. The disclosed herbo-mineral formulation includes herb and mineral elements which facilitate in treating Diabetes and Diabetes associated complications. Further the disclosed formulation has been observed to exhibit hypoglycemic, hypolipidemic, and pancreatic cell regenerative properties.

公开(公告)号：US20180236018A1

公开(公告)日：2018-08-23

申请号：US15960343

申请日：2018-04-23

Applicant: Muniyal Ayurvedic Research Centre

Inventor： M Vijayabhanu SHETTY

IPC: A61K36/37 ,  A61K36/24 ,  A61K36/61 ,  A61K36/9066 ,  A61K36/328 ,  A61K36/59 ,  A61K45/06 ,  A61P3/10

CPC classification number: A61K36/37 ,  A61K33/30 ,  A61K35/614 ,  A61K36/185 ,  A61K36/24 ,  A61K36/328 ,  A61K36/59 ,  A61K36/61 ,  A61K36/67 ,  A61K36/9066 ,  A61K36/9068 ,  A61K45/06 ,  A61K2300/00 ,  A61P3/10

Abstract: Herbo-mineral formulation for prevention, treatment and management of Diabetes and method of preparing the same are disclosed herein. The disclosed herbo-mineral formulation includes herb and mineral elements which facilitate in treating Diabetes and Diabetes associated complications. Further the disclosed formulation has been observed to exhibit hypoglycemic, hypolipidemic, and pancreatic cell regenerative properties.

公开(公告)号：US09913870B2

公开(公告)日：2018-03-13

申请号：US14368888

申请日：2013-01-11

Applicant: DHARMA BIOMEDICAL, LLC ,  FLAVEX NATUREXTRAKTE GMBH

Inventor： Steven J. Melnick ,  Karl-Werner Quirin ,  Cheppail Ramachandran ,  Melvin Rothberg

IPC: A61K36/328 ,  A61K8/97 ,  A61Q19/08 ,  A61Q19/00

CPC classification number: A61K36/328 ,  A61K8/97 ,  A61Q19/004 ,  A61Q19/08

Abstract: The subject invention pertains to supercritical carbon dioxide extracts of Commiphora mukul resin (guggul), which can be modified or not modified by some ethanol addition; methods for their production; and methods of use, such as inhibiting HMG-CoA reductase, inhibiting transformation of pre-adipocytes to adipocytes, inhibiting triglyceride storage, promoting insulin sensitivity in adipocytes, treatment of disorders (for example, hypercholesterolemia, hyperlipidemia, hyperglycemia, obesity, metabolic syndrome, cardiovascular disease, atherosclerotic heart disease, autoimmune disorder, insulin resistance, leptin resistance, arthritis, cell proliferation disorder, such as cancer and atherosclerosis; damaged skin, sores, cuts, rashes, bruises, dryness, burns, sunburn, radiation burn, and infection), and regulating or suppressing appetite.

公开(公告)号：US09855307B2

公开(公告)日：2018-01-02

申请号：US14206322

申请日：2014-03-12

Applicant: IZUN PHARMACEUTICALS CORPORATION

Inventor： William Z. Levine ,  Aron J. Saffer ,  Mina Fran

IPC: A61K36/28 ,  A61K36/23 ,  A61K36/185 ,  A61K36/328 ,  A61K36/35 ,  A61K36/38 ,  A61K9/00 ,  A61K45/06

CPC classification number: A61K36/28 ,  A61K9/0031 ,  A61K9/006 ,  A61K36/185 ,  A61K36/23 ,  A61K36/328 ,  A61K36/35 ,  A61K36/38 ,  A61K45/06 ,  A61K2300/00

Abstract: The present invention provides therapeutic compositions comprising extracts of the plant species Echinacea purpurea and Sambucus nigra and the extract(s) of at least one further plant selected from the group consisting of Hypericum perforatum, Commiphora molmol and Centella asiatica. The compositions of the invention are of particular utility in the management of inflammatory mucosal diseases of both viral and non-viral origin.

公开(公告)号：US20170360815A1

公开(公告)日：2017-12-21

申请号：US15691648

申请日：2017-08-30

Applicant: APPLIED BIOLOGICAL LABORATORIES, INC.

Inventor： Nazlie LATEFI

IPC: A61K31/7012 ,  A61K38/40 ,  A61K31/7016 ,  C12N9/24 ,  A61K31/05

CPC classification number: A61K31/7012 ,  A61K9/0019 ,  A61K9/0043 ,  A61K9/0073 ,  A61K31/05 ,  A61K31/352 ,  A61K31/7016 ,  A61K33/30 ,  A61K33/34 ,  A61K33/38 ,  A61K36/28 ,  A61K36/328 ,  A61K36/53 ,  A61K36/752 ,  A61K38/1774 ,  A61K38/40 ,  A61K38/47 ,  A61K45/06 ,  A61K47/10 ,  A61K47/26 ,  A61K47/44 ,  A61P11/00 ,  A61P31/00 ,  C12N9/24 ,  C12N2760/16263 ,  C12Y302/01017 ,  A61K2300/00

Abstract: The present disclosure features methods and compositions for enhancing the ability of the respiratory membranes to filter airborne pathogens and protect a subject from respiratory infections that result from inhalation or ingestion of such pathogens. In particular, the disclosure provides antimicrobial compositions that prevent and treat respiratory infections caused by bacteria, fungi, and viruses.

公开(公告)号：US09795634B1

公开(公告)日：2017-10-24

申请号：US15051977

申请日：2016-02-24

Applicant: Sherita L. Moses

Inventor： Sherita L. Moses

IPC: B82Y30/00 ,  A61K33/24 ,  A61K9/51 ,  A61K9/00

CPC classification number: A61K33/24 ,  A61K9/0019 ,  A61K9/14 ,  A61K9/5176 ,  A61K31/19 ,  A61K31/194 ,  A61K36/324 ,  A61K36/328 ,  A61K45/06 ,  B82Y5/00 ,  B82Y30/00 ,  A61K2300/00

Abstract: The present disclosure generally pertains to systems and methods for the treatment of cancer. Disclosed herein are compositions for the treatment of cancer, such compositions comprising a plurality of gold nanoparticles coated with citrate ions, frankincense and myrrh. Also disclosed herein are methods for the treatment of cancer, such methods comprising the administration of a plurality of gold nanoparticles coated with citrate ions, frankincense and myrrh.

公开(公告)号：US20160324971A1

公开(公告)日：2016-11-10

申请号：US15111916

申请日：2015-01-19

Applicant: Ahmet KILIC

Inventor： AHMET KILIC ,  HASAN CICEK

IPC: A61K47/34 ,  A61K31/155 ,  A61K36/328 ,  A61K47/18 ,  A61K9/06 ,  A61K47/38 ,  A61L26/00 ,  A61K47/26 ,  A61K36/30 ,  A61K9/00

CPC classification number: A61K47/34 ,  A61K9/0014 ,  A61K9/006 ,  A61K9/06 ,  A61K31/155 ,  A61K36/30 ,  A61K36/328 ,  A61K47/10 ,  A61K47/18 ,  A61K47/186 ,  A61K47/26 ,  A61K47/38 ,  A61L26/0019 ,  A61L26/0023 ,  A61L26/0052 ,  A61L26/0057 ,  A61L26/0066 ,  A61L26/008 ,  A61L2300/206 ,  A61L2300/30 ,  A61L2300/404 ,  A61L2430/34 ,  A61K2300/00

Abstract: The present invention relates to new formulations, particularly useful in the topical treatment of skin and oromucosal wounds. Formulations can be either a solution or a gel form consisting of a Polyhexamethylene biguanide as an antimicrobial agent, purified water and a tri-blockcopolymer, particularly a triblockcopolymer of polyethylene oxide and polypropylene oxide, and more particularly a poloxamer.

Abstract translation: 本发明涉及特别可用于局部治疗皮肤和粘膜损伤的新制剂。 制剂可以是由作为抗微生物剂的聚六亚甲基双胍制成的溶液或凝胶形式，纯化水和三嵌段共聚物，特别是聚环氧乙烷和聚环氧丙烷的三嵌段共聚物，更特别是泊洛沙姆。